Experienced in Becker Muscular Dystrophy

Dr. Lindsey A. George

Family Medicine
1801 Windsor Rd, 
Champaign, IL 
Experienced in Becker Muscular Dystrophy
1801 Windsor Rd, 
Champaign, IL 
OverviewInsuranceLocationsClinical Research

Overview

Lindsey George is a primary care provider, practicing in Family Medicine in Champaign, Illinois. Dr. George is rated as an Experienced provider by MediFind in the treatment of Becker Muscular Dystrophy. Her top areas of expertise are Hemophilia B, Hemophilia A, Blood Clots, and Familial Glucocorticoid Deficiency.

Her clinical research consists of co-authoring 50 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Becker Muscular Dystrophy.

Specialties
Family Medicine
Licenses
Family Medicine in IL
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

1801 Windsor Rd, Champaign, IL 61822

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Gene-transfer, Open-label, Dose-escalation Study of SPK-8011 [Adeno-associated Viral Vector With B-domain Deleted Human Factor VIII Gene] in Individuals With Hemophilia A
Gene-transfer, Open-label, Dose-escalation Study of SPK-8011 [Adeno-associated Viral Vector With B-domain Deleted Human Factor VIII Gene] in Individuals With Hemophilia A
Enrollment Status: Completed
Publish Date: December 30, 2024
Intervention Type: Genetic
Study Drug: SPK-8011
Study Phase: Phase 1/Phase 2
Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors
Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors
Enrollment Status: Completed
Publish Date: February 23, 2024
Intervention Type: Genetic
Study Drug: SPK-8016 Adeno-Associated Viral Vector Vaccine
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

50 Total Publications

The future of gene therapy: Safer vectors, sharper focus: High-profile failures demand deep root cause analysis - but the transformative potential of AAV remains within reach if the field is willing to learn and evolve.
The future of gene therapy: Safer vectors, sharper focus: High-profile failures demand deep root cause analysis - but the transformative potential of AAV remains within reach if the field is willing to learn and evolve.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: August 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. George's expertise for a condition
ConditionClose
      View All 11 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile